Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c60b9f0d36836a44bc0184185e8f587a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0723ac2f397223ca017c2963d0a599e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e97a49f4530a262151505562cdf7ce10 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08 |
filingDate |
2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e77c261ebc816ea701e9a05d5090e31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_255140e29844d723db7d74417d9bb304 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a9724e325405cc6fa47837b1b5668bc |
publicationDate |
2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014152121-A1 |
titleOfInvention |
Mono or multivalent botulinum neurotoxin based vaccine using the heavy chain from serotypes of clostridium botulinum |
abstract |
Disclosed herein are compositions and methods for treating Clostridium botulinum neurotoxin intoxication and in particular, vaccines against the neurotoxin that provide protection again lethal challenge with neurotoxin from one or more serotypes of Clostridium botulinum. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707510-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019158745-A1 |
priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |